Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DTaP vaccine (BK1301) booster in adolescents
NCT02118961Phase 3Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Apr 2014
- Primary completion
- Aug 2014
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of TRIBIK in diphtheria, Tetanus, pertussis, sponsored by Mitsubishi Tanabe Pharma. Started Apr 2014; status: completed.
02
Drugs
TRIBIK
03
Conditions
diphtheriaTetanuspertussis
Beyond the preview
Go deeper on NCT02118961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02118961.